Imaging Analysis for Drug Discovery & Development
Drug Targets Imaging Analysis
CD BioSciences offers imaging analysis services for a variety of drug targets, providing insights into the target structures and their interactions with other proteins. This comprehensive information enables researchers to thoroughly investigate the targets of interest, ensuring that further drug research and development proceed on a well-informed foundation.
Imaging Monitoring of Biomarkers in Tissues
CD BioSciences has a professional team and advanced imaging equipment. The entire process of imaging monitoring of biomarkers in tissues is operated by experienced technicians to ensure the accuracy of the experiment. With a wealth of experience in discovering new biomarkers and monitoring existing ones in tissues, we contribute significantly to the development of new drugs and the diagnosis of diseases.
Providing Customized Imaging Technology Services to Accelerate Drug Research and Development
CD BioSciences offers comprehensive in vitro and in vivo imaging services to support your research needs. Our advanced imaging platforms and experienced team provide high-resolution images and quantitative data for a wide range of applications, including preclinical pathological research and drug development. We utilize various imaging modalities, ensuring the selection of the most appropriate technique for your specific project goals.
Imaging in Disease Models
CD BioSciences provides imaging services in disease models, offering high-resolution data for preclinical research and development.
Pharmacokinetic Imaging Services
CD BioSciences provides data on the absorption, distribution, metabolism, and clearance of new therapeutic candidates utilizing advanced imaging equipment.
In Vivo Drug Efficacy Imaging Monitoring
The entire process of in vivo drug efficacy imaging monitoring is operated by experienced technicians to ensure the accuracy of the experiment.
Drug Toxicity Imaging Services
Through the high-content imaging analysis system, we provide drug toxicity imaging analysis services at the preclinical drug development stage.